Back
Charter Communications, Inc. Vs. Lyell Immunopharma, Inc. Industry Stock Comparison
Sell
11
CHTR
Charter Communications, Inc.
Last Price:
$205.25
Seasonality Move:
6.54%
Buy
61
LYEL
Lyell Immunopharma, Inc.
Last Price:
$37.17
Seasonality Move:
-16.78%
Sell
11
Charter Communications, Inc. (CHTR)
is a Sell
Is Charter Communications, Inc. a Buy, Sell or Hold?
-
The current Charter Communications, Inc. [CHTR] share price is $205.28. The Score for CHTR is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.
-
CHTR is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
61
Lyell Immunopharma, Inc. (LYEL)
is a Buy
Is Lyell Immunopharma, Inc. a Buy, Sell or Hold?
-
The current Lyell Immunopharma, Inc. [LYEL] share price is $37.33. The Score for LYEL is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
-
LYEL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CHTR Stock Price Chart
What is Charter Communications, Inc.'s stock price today?
-
The Charter Communications, Inc. share price today is $205.28Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CHTR is experiencing slight selling pressure.
LYEL Stock Price Chart
What is Lyell Immunopharma, Inc.'s stock price today?
-
The Lyell Immunopharma, Inc. share price today is $37.33Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LYEL is experiencing selling pressure, which indicates risk of future bearish movement.
CHTR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.34 | Sell |
| Relative Strength Index (14 RSI): | 44.15 | Sell |
| Chaikin Money Flow: | -225548 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (198.32 - 208.64) | Buy |
| Bollinger Bands (100): | (213.91 - 270.81) | Sell |
LYEL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.24 | Buy |
| Relative Strength Index (14 RSI): | 78.97 | Buy |
| Chaikin Money Flow: | -246560 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (20.8 - 33.24) | Buy |
| Bollinger Bands (100): | (10.76 - 24.28) | Buy |
CHTR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 207.48 | Sell |
| 20-day SMA: | 204.77 | Buy |
| 50-day SMA: | 218.25 | Sell |
| 200-day SMA: | 309.32 | Sell |
| 8-day EMA: | 206.66 | Sell |
| 20-day EMA: | 207.27 | Sell |
| 50-day EMA: | 220.3 | Sell |
| 200-day EMA: | 283.58 | Sell |
LYEL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 34 | Buy |
| 20-day SMA: | 29.06 | Buy |
| 50-day SMA: | 22.08 | Buy |
| 200-day SMA: | 13.64 | Buy |
| 8-day EMA: | 33.98 | Buy |
| 20-day EMA: | 29.78 | Buy |
| 50-day EMA: | 23.99 | Buy |
| 200-day EMA: | 17.62 | Buy |
Charter Communications, Inc. Earnings Growth & CHTR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.45 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.29 per share, and an increase next year of $6.91 per share.
Lyell Immunopharma, Inc. Earnings Growth & LYEL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $9.86 per share, and a decrease next year of $3.96 per share.
Charter Communications, Inc. Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Lyell Immunopharma, Inc. Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||